SWOT Analysis for Revolution Medicines Inc

Positive Breakout First Resistance ( LTP > R1)
Consistent Highest Return Stocks over Five Years
Relative Outperformance versus Industry over the Quarter (3 Months)
Good Aggregate Candlestick Strength (total bullish - bearish candlesticks)
Relative Outperformance versus Industry over 1 Week
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Companies with Low Debt
Positive Breakout (LTP > R1)
Top Gainers
Stock with Low PE (PE < = 10)
Stocks Outperforming their Industry Price Change in the Quarter

PEG greater than Industry PEG
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
Degrowth in Quarterly Revenue and Profit in Recent Results(YoY)
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Annual net profit declining for last 2 years
Declining profits every quarter for the past 3 quarters